Publications
- Efficacy of weekly transtuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes2002 | First Faculty of Medicine
- Weekly Administration of Trastuzumab (T) and Paclitaxel (P) in thePublication without faculty affiliation
- Weekly trastuzumab (T) and paclitaxel (P) in metastatic breast cancer (MBC). The impact of taxane free interval (TFI) on treatment outcomePublication without faculty affiliation
- První zkušenosti s kombinovanou imunoterapií2021 | Publication without faculty affiliation
- A patient with a tumour of unknown primary origin: treatment and course of the disease2020 | Publication without faculty affiliation
- Gene Expression Analysis of Immunomagnetically Enriched Circulating Tumor Cell Fraction in Castration-Resistant Prostate Cancer2018 | First Faculty of Medicine, Central Library of Charles University
- Neuroendocrine tumors in cases2018 | First Faculty of Medicine
- Neuroendokrinní nádory2016 | First Faculty of Medicine, Third Faculty of Medicine
- Prognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest(R) System for Detection of Circulating Tumor Cells2016 | First Faculty of Medicine
- Circulating tumor cells and prostate cancer prognosis2014 | First Faculty of Medicine, Third Faculty of Medicine
Loading network view...